First, we analyzed the capability of the designed peptides to prevent PSD-95 processing induced in vitro by purified calpain I in extracts prepared from adult brain cortex (Figure 5B-C), the intended target of neuroprotection in our stroke model. The gene discussed is DLG4; the disease is stroke disorder.